The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Monsanto's revenues will expand 8.1% and EPS will grow 56.5%.
The average estimate for revenue is $2.64 billion. On the bottom line, the average EPS estimate is $0.36.
Last quarter, Monsanto reported revenue of $2.11 billion. GAAP reported sales were 6.6% lower than the prior-year quarter's $2.25 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at -$0.45. GAAP EPS were -$0.43 for Q4 versus -$0.21 per share for the prior-year quarter.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 42.3%, 100 basis points worse than the prior-year quarter. Operating margin was -8.8%, 530 basis points worse than the prior-year quarter. Net margin was -10.9%, 590 basis points worse than the prior-year quarter.
The full year's average estimate for revenue is $14.61 billion. The average EPS estimate is $4.40.
The stock has a three-star rating (out of five) at Motley Fool CAPS, with 2,837 members out of 2,974 rating the stock outperform, and 137 members rating it underperform. Among 614 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 586 give Monsanto a green thumbs-up, and 28 give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Monsanto is outperform, with an average price target of $93.89.
The rich are different than you and me: They might not notice the moneymaking stories right under our noses. In our new report, "Middle-Class Millionaire-Makers: 3 Stocks Wall Street's Too Rich to Notice," we give you three Peter Lynch-inspired buy-what-you-know stocks for the 99%. Click here for instant access to this free report.
- Add Monsanto to My Watchlist.